Similar articles for PMID: 19734408

Year	Number of Results
1977	1
1988	2
1993	1
1994	1
1995	1
1996	2
1997	1
2003	4
2004	1
2005	8
2006	5
2007	5
2008	1
2009	6
2011	1
2012	2
2015	1
2018	1
2020	1
2024	0

1

Re: Myocardial infarction associated with Adderall XR and alcohol use in a young man.

Pomeroy D. Pomeroy D. J Am Board Fam Med. 2009 Sep-Oct;22(5):590; author reply 590. doi: 10.3122/jabfm.2009.05.090048. J Am Board Fam Med. 2009. PMID: 19734408 Free article. No abstract available.

2

Myocardial infarction associated with adderall XR and alcohol use in a young man.

Jiao X, Velez S, Ringstad J, Eyma V, Miller D, Bleiberg M. Jiao X, et al. J Am Board Fam Med. 2009 Mar-Apr;22(2):197-201. doi: 10.3122/jabfm.2009.02.080003. J Am Board Fam Med. 2009. PMID: 19264944 Free article.

3

Adderall XR: long acting stimulant for single daily dosing.

Sallee FR, Smirnoff AV. Sallee FR, et al. Expert Rev Neurother. 2004 Nov;4(6):927-34. doi: 10.1586/14737175.4.6.927. Expert Rev Neurother. 2004. PMID: 15853519 Review.

4

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.

Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins SH, Clark TM, Mays DA, Zhang Y, Tulloch SJ. Wigal SB, et al. J Atten Disord. 2005 Aug;9(1):275-89. doi: 10.1177/1087054705281121. J Atten Disord. 2005. PMID: 16371674 Clinical Trial.

5

Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report.

Matsumoto T, Kamijo A, Yamaguchi A, Iseki E, Hirayasu Y. Matsumoto T, et al. Psychiatry Clin Neurosci. 2005 Feb;59(1):102-5. doi: 10.1111/j.1440-1819.2005.01340.x. Psychiatry Clin Neurosci. 2005. PMID: 15679548 Free article.

6

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Spencer TJ, et al. Clin Ther. 2006 Feb;28(2):266-79. doi: 10.1016/j.clinthera.2006.02.011. Clin Ther. 2006. PMID: 16678648 Clinical Trial.

7

I Have Never Used Methamphetamine, But My Urinalysis Says I Do.

Sethi R, Din A, McAllister R, Lester A. Sethi R, et al. Prim Care Companion CNS Disord. 2018 Oct 18;20(5):17l02129. doi: 10.4088/PCC.17l02129. Prim Care Companion CNS Disord. 2018. PMID: 30407755 Free article. No abstract available.

8

Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Upadhyaya HP. Upadhyaya HP. J Clin Psychiatry. 2007;68 Suppl 11:23-30. J Clin Psychiatry. 2007. PMID: 18307378 Review.

9

Acute myocardial infarction in a teenager due to Adderall XR.

Sylvester AL, Agarwala B. Sylvester AL, et al. Pediatr Cardiol. 2012 Jan;33(1):155-7. doi: 10.1007/s00246-011-0083-9. Epub 2011 Aug 13. Pediatr Cardiol. 2012. PMID: 21842255

10

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT. Chavez B, et al. Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Ann Pharmacother. 2009. PMID: 19470858 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year